ASDSA Recognizes 2024 Patient Safety Hero Award Honorees
October 16, 2024 07:00 ET
|
American Society for Dermatologic Surgery Association
Schaumburg, IL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA) is pleased to announce the recipients of its annual Patient Safety Hero...
2024 ASDSA Top Advocates Chosen
October 16, 2024 07:00 ET
|
American Society for Dermatologic Surgery Association
Schaumburg, IL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA) is pleased to announce the 2024 Top Advocates during the ASDS / ASDSA Annual...
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice
October 10, 2024 12:24 ET
|
Olansky Dermatology & Aesthetics
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky
retires after more than 40 years of clinical practice.
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
October 03, 2024 08:30 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses...
ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth
October 03, 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma post strong Q2 results
Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
September 25, 2024 08:16 ET
|
Spherix Global Insights
EXTON, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm, is expanding its specialized offerings to buy-side financial firms...
Kymera Therapeutics Presents Preclinical Data for KT-621, a Potent, Selective, First-In-Class, Oral STAT6 Degrader at the EADV Congress
September 25, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic disease KT-621 demonstrated strong degradation of STAT6 in human...
Despite Projections of a 2024 Adalimumab Biosimilar Boom, Humira Remains Dominant for Now, According to Spherix Global Insights
September 23, 2024 10:18 ET
|
Spherix Global Insights
EXTON, PA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights compiled data from their RealTime Dynamix™ services in Crohn’s Disease, Rheumatoid Arthritis, and Psoriasis, fielded in late...
Leading Dermatologic Associations and Skin Cancer Prevention Organizations Urge U.S. Surgeon General to Renew Skin Cancer Call to Action
September 18, 2024 12:46 ET
|
American Society for Dermatologic Surgery Association
Schaumburg, Ill., Sept. 18, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA), in conjunction with the American Academy of Dermatology Association (AAD), the...
ASDS Experts Share Procedural Dermatology Techniques at Unique Hands-on Course With Innovative 3D Technology
September 16, 2024 07:00 ET
|
American Society for Dermatologic Surgery
Schaumburg, IL, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery (ASDS) welcomed more than 50 dermatologic surgeons and dermatology residents to its new course, “ASDS...